Cigna Corp (CI): Today's Featured Health Care Loser

Cigna ( CI) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 0.4%. By the end of trading, Cigna fell 26 cents (-0.6%) to $42.97 on average volume. Throughout the day, three million shares of Cigna exchanged hands as compared to its average daily volume of 2.7 million shares. The stock ranged in price between $42.74-$43.46 after having opened the day at $43.33 as compared to the previous trading day's close of $43.23. Other company's within the Health Care sector that declined today were: Savient Pharmaceuticals ( SVNT), down 15.5%, CombiMatrix Corporation ( CBMX), down 14.9%, Sunshine Heart ( SSH), down 14.8%, and IsoRay ( ISR), down 14.6%.

CIGNA Corporation, a health services organization, through its subsidiaries, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $12.58 billion and is part of the health services industry. The company has a P/E ratio of 9.5, below the average health services industry P/E ratio of 9.6 and below the S&P 500 P/E ratio of 17.7. Shares are up 3.9% year to date as of the close of trading on Monday. Currently there are 11 analysts that rate Cigna a buy, no analysts rate it a sell, and six rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, StemCells ( STEM), up 106.9%, Peregrine Pharmaceuticals ( PPHM), up 26.4%, Allos Therapeutics ( ALTH), up 21.7%, and Hemispherx Biopharma ( HEB), up 20.5%, were all gainers within the health care sector with Amgen ( AMGN) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Snap and Coca-Cola Are Among 16 Stocks That Are Ready to Change Direction

Snap and Coca-Cola Are Among 16 Stocks That Are Ready to Change Direction

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

Can Buffett and a Couple of Rich Celebrity CEOs Really Fix Healthcare?

Can Buffett and a Couple of Rich Celebrity CEOs Really Fix Healthcare?